Free Delivery
Free delivery for purchases over €350
LETROZOLE is an oral medication indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. It is a selective, non-steroidal aromatase inhibitor that significantly lowers serum estradiol levels and has no effect on the formation of adrenal corticosteroids or aldosterone.
Composition:
Letrozole USP 2.5 mg Hard tablets Each box contains 50 tablets
Storage:
Store at room temperature between 15 oC – 30 oC, away from light and moisture. Do not store in the bathroom. Keep all medicines away from children and pets.